Yıl: 2021 Cilt: 32 Sayı: 4 Sayfa Aralığı: 363 - 373 Metin Dili: İngilizce DOI: 10.5152/tjg.2020.20674 İndeks Tarihi: 29-05-2022

Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS

Öz:
Background: There has been no valid and reliable Turkish scale that measures symptoms in children with eosinophilic esophagitis (EoE). The aim of the study is to test the validity and reliability of the Turkish version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0). Methods: Relevant forms of Tr-PEESS v2.0 were applied to 2-18 years old children with EoE and to their parents. KINDL QoL patient and parent questionnaires and the GaziESAS scale developed in this study were used to test the convergent validity of Tr-PEESS v2.0. Discriminant validity was evaluated among 3 EoE treatment groups: under treatment, off treatment due to remission, and uncompliant with treatment. Reliability was evaluated by internal consistency, test–retest reliability, and item analysis. Results: Fifty-two children/teens (mean age 130.2 ± 60.3 months) and 84 parents were interviewed twice one week apart. The mean duration of EoE was 47.2 ± 35.6 months. Tr-PEESS v2.0 reports correlated with GaziESAS (range 0.361-0.855) and KINDL QoL questionnaires (range −0.316 to 0.413). Parent report of Tr-PEESS v2.0 discriminated children uncompliant with treatment from the ones off treatment and undertreatment. Cronbach’s α values and intraclass correlation coefficients (ICC) values of Tr-PEESS v2.0 ranged from 0.614-0. 895 and 0.646-0.910, respectively. Conclusion: Tr-PEESS v2.0 is a valid and reliable tool to use in Turkish children. GaziESAS is a new parent-proxy pediatric EoE scale with an additional adaptive behavior domain that passed scale developmental stages successfully for Turkish children with EoE. Keywords: Children, eosinophilic esophagitis, reliability, scale, validity
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Munoz-Persy M, Lucendo AJ. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach. Eur J Pediatr. 2018;177(5):649-663. [CrossRef].
  • 2. Hirano I, Furuta GT. Approaches and challenges to management of pediatric and adult patients with eosinophilic esophagitis. Gastroenterology. 2020;158(4):840-851. [CrossRef].
  • 3. Franciosi JP, Hommel KA, DeBrosse CW, et al. Development of a validated patient-reported symptom metric for pediatric eosinophilic esophagitis: qualitative methods. BMC Gastroenterol. 2011;11:126. [CrossRef].
  • 4. Martin LJ, Franciosi JP, Collins MH, et al. Pediatric eosinophilic esophagitis symptom scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. J Allergy Clin Immunol. 2015;135(6):1519-28.e8. [CrossRef].
  • 5.Lucendo AJ, Molina-Infante J, Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.U Eur Gastroenterol J. 2017 ;5(3):335-358. [CrossRef].
  • 6. Mapi research trust. France: PEESS v2.0 contact information and permission to use. http://www.mapitrust.org; 2020.
  • 7.Ravens-Sieberer U, Erhart M, Wille N, et al. Generic health-related quality-of-life assessment in children and adolescents: methodological considerations. Pharmacoeconomics. 2006;24(12):1199- 1220. [CrossRef].
  • 8. Eser E, Yüksel H, Baydur H, et al. The psychometric properties of the new Turkish generic health-related quality of life questionnaire for children (Kid-KINDL). Turk Psikiyatri Derg. 2008;19(4):409-417. PMID: 19110983
  • 9. Ebadi A, Zarshenas L, Rakhshan M, et al. Fundamentals of Scale Validation in Health Sciences. Tehran, Iran: Jame’e Negar; 2016 ( in Persian).
  • 10. Lawshe CH. A quantitative approach to content validity. Pers Psychol. 1975;28(4):563-575. [CrossRef].
  • 11. Polit DF, Beck CT, Owen SV. : Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459-467. [CrossRef].
  • 12. Davis LL. Instrument review: getting the most from your panel of experts. Appl Nurs Res ANR. 1992;5(4):194-197. [CrossRef].
  • 13. Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005;19(1):231-240. [CrossRef].
  • 14. Gregory R. J. Psychology Testing: History, Principles, and Applications. 5th ed; 2007. Boston: Ally & Bacon. (w).
  • 15. Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763-1768. [CrossRef].
  • 16. Meirte J, Van Daele U, Maertens K, et al. Convergent and discriminant validity of quality of life measures used in burn populations. Burns. 2017;43(1):84-92. [CrossRef].
  • 17. Tyack Z, Simons M, Spinks A, Wasiak J. A systematic review of the quality of burn scar rating scales for clinical and research use. Burns. 2012;38(1):6-18. [CrossRef].
  • 18. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293-307. [CrossRef].
  • 19. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42. [CrossRef].
  • 20. Johnson R.L., Morgan G.B. Survey Scales: Investigating Scale Quality. New York, NY: The Guilford Press; 2016.
  • 21. Carlstedt E, Lexell EM, Pessah-Rasmussen H, Iwarsson S. Psychometric properties of the Swedish version of the Generel Self-Efficacy Scale in stroke survivor. Int J Rehabil Res. 2015;38(4):333-337. [CrossRef].
  • 22. Voigt-Radloff S, Leonhart R, Schützwohl M, et al. Dementia quality of life instrument--construct and concurrent validity in patients with mild to moderate dementia. Eur J Neurol. 2012;19(3):376-384. [CrossRef].
  • 23. Santos MFO, Barros CP, Silva CHMD, Paro HBMDS. Translation and cultural adaptation of the Pediatric Eosinophilic esophagitis Symptom Score (PEESS v2.0). J Pediatr (Rio J). 2018;94(6):642-651. [CrossRef].
  • 24. Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best practices for developing and validating scales for health, social, and behavioral research: A primer. Front Public Health. 2018;6:149. [CrossRef].
  • 25. Tsang S, Royse CF, Terkawi AS. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth. 2017;11(Suppl 1)(suppl 1):S80-S89. [CrossRef].
APA Ertoy Karagol H, BAKIRTAS A, Yapar D, İLHAN M, Egritas Gurkan O, Sarı S, DALGIÇ B (2021). Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. , 363 - 373. 10.5152/tjg.2020.20674
Chicago Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU,Yapar Dilek,İLHAN Mustafa Necmi,Egritas Gurkan Odul,Sarı Sinan,DALGIÇ Buket Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. (2021): 363 - 373. 10.5152/tjg.2020.20674
MLA Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU,Yapar Dilek,İLHAN Mustafa Necmi,Egritas Gurkan Odul,Sarı Sinan,DALGIÇ Buket Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. , 2021, ss.363 - 373. 10.5152/tjg.2020.20674
AMA Ertoy Karagol H,BAKIRTAS A,Yapar D,İLHAN M,Egritas Gurkan O,Sarı S,DALGIÇ B Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. . 2021; 363 - 373. 10.5152/tjg.2020.20674
Vancouver Ertoy Karagol H,BAKIRTAS A,Yapar D,İLHAN M,Egritas Gurkan O,Sarı S,DALGIÇ B Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. . 2021; 363 - 373. 10.5152/tjg.2020.20674
IEEE Ertoy Karagol H,BAKIRTAS A,Yapar D,İLHAN M,Egritas Gurkan O,Sarı S,DALGIÇ B "Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS." , ss.363 - 373, 2021. 10.5152/tjg.2020.20674
ISNAD Ertoy Karagol, Hacer Ilbilge vd. "Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS". (2021), 363-373. https://doi.org/10.5152/tjg.2020.20674
APA Ertoy Karagol H, BAKIRTAS A, Yapar D, İLHAN M, Egritas Gurkan O, Sarı S, DALGIÇ B (2021). Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. Turkish Journal of Gastroenterology, 32(4), 363 - 373. 10.5152/tjg.2020.20674
Chicago Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU,Yapar Dilek,İLHAN Mustafa Necmi,Egritas Gurkan Odul,Sarı Sinan,DALGIÇ Buket Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. Turkish Journal of Gastroenterology 32, no.4 (2021): 363 - 373. 10.5152/tjg.2020.20674
MLA Ertoy Karagol Hacer Ilbilge,BAKIRTAS ARZU,Yapar Dilek,İLHAN Mustafa Necmi,Egritas Gurkan Odul,Sarı Sinan,DALGIÇ Buket Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. Turkish Journal of Gastroenterology, vol.32, no.4, 2021, ss.363 - 373. 10.5152/tjg.2020.20674
AMA Ertoy Karagol H,BAKIRTAS A,Yapar D,İLHAN M,Egritas Gurkan O,Sarı S,DALGIÇ B Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. Turkish Journal of Gastroenterology. 2021; 32(4): 363 - 373. 10.5152/tjg.2020.20674
Vancouver Ertoy Karagol H,BAKIRTAS A,Yapar D,İLHAN M,Egritas Gurkan O,Sarı S,DALGIÇ B Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS. Turkish Journal of Gastroenterology. 2021; 32(4): 363 - 373. 10.5152/tjg.2020.20674
IEEE Ertoy Karagol H,BAKIRTAS A,Yapar D,İLHAN M,Egritas Gurkan O,Sarı S,DALGIÇ B "Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS." Turkish Journal of Gastroenterology, 32, ss.363 - 373, 2021. 10.5152/tjg.2020.20674
ISNAD Ertoy Karagol, Hacer Ilbilge vd. "Reliability and Validity Study of Turkish Version of Pediatric Eosinophilic Esophagitis Symptom Scores® (Tr-PEESS v2.0) Led to Development of a New Pediatric Eosinophilic Esophagitis Scale: GaziESAS". Turkish Journal of Gastroenterology 32/4 (2021), 363-373. https://doi.org/10.5152/tjg.2020.20674